Research

Oral impact

Poor oral health has been linked to a 75 per cent increased risk of the most common form of liver cancer.

Welsh pharmacy flu jab success

Researchers from the Cardiff School of Pharmacy and Pharmaceutical Sciences analysed records of flu vaccinations delivered in community pharmacies

Anti-inflammatories boost antidepressants

A meta-analysis of 36 randomised controlled studies suggests that concomitant anti-inflammatories can improve antidepressant effectiveness

Inflammation may contribute to depression

A new Canadian study reports that psychiatric conditions may emerge five years before the diagnosis of inflammatory diseases

Younger diagnosis, worse prognosis for type 2 diabetes

People diagnosed with type 2 diabetes at about 15 years of age lost a median of approximately 12 years of life in a recent study

Simple regimen needed for HCV

Combining sofosbuvir and velpatasvir offers “a simple, effective regimen for the treatment of chronic hepatitis C” (HCV) infection, according to new research

Oral infections in childhood linked to adult CVD

Oral infections during childhood may increase the risk of developing cardiovascular disease (CVD) in later life, according to a study from Finland

Statins don’t lower LDL-C optimally in all patients

More than half of patients do not show optimal reductions in low-density lipoprotein cholesterol (LDL-C) within two years of starting statins, Heart reports

Cannabidiol ‘almost halves’ epilepsy seizures

The study reported that 10 and 20mg/kg cannabidiol reduced the frequency of convulsive seizures by 49 and 46 per cent respectively compared with baseline

Diabetes screening costs in pharmacy similar to GPs

The economic analysis used data collected from 172 patients from six pharmacies in Leicester and 164 patients from six pharmacies in Surrey

Tramadol associated with higher mortality in OA

Tramadol is associated with significantly higher mortality than non-steroidal antiinflammatory drugs in people with osteoarthritis

Second-hand smoke raises risk of kidney disease

Exposure to second-hand smoke is associated with a greater risk of developing chronic kidney disease (CKD), say Korean researchers

New asthma treatment

The CHMP has approved dupilumab (Dupixent) as add-on maintenance treatment for some patients 12 years and older with severe asthma

HbA1c misses many cases of diabetes

“Our results indicated that the prevalence of diabetes and normal glucose tolerance defined solely by A1c is highly unreliable," said a researcher

ADHD treatments can trigger psychosis

About one in 660 adolescents and young adults receiving prescription stimulants for attention deficit hyperactivity disorder (ADHD) develop psychosis

MS drug improves survival

Beta-interferons produce “a significant survival advantage among people with relapsing-onset multiple sclerosis” (RRMS), according to a new study

New class of haemophilia A treatment

The European Commission recently approved emicizumab (Hemlibra) to prevent bleeding episodes in people with severe haemophilia A

Asthma rates falling

Researchers found that 6.52 per cent of the UK population had asthma in 2016 compared with 7.22 per cent in 2006

HCV: DAAs reduce deaths and cancer

Direct-acting antivirals (DAA) seem to reduce mortality and hepatocellular carcinoma in people with chronic hepatitis C

Antipsychotics increase type 2 diabetes risk

Patients taking certain antipsychotics appear to be at increased risk of developing type 2 diabetes, BMJ Open reports

Previous 1 2 3 4 5 ... 9 Next


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.